Droplet-like clusters reveal new control switch for major drug-target receptors
A study by researchers at Duke University School of Medicine identifies a new way that G protein–coupled receptors (GPCRs)—targets of roughly one-third of FDA-approved drugs—control signaling in cells. The paper is published in the journal Nature.
Image: Phys.org
A study by researchers at Duke University School of Medicine identifies a new way that G protein–coupled receptors (GPCRs)—targets of roughly one-third of FDA-approved drugs—control signaling in cells. The paper is published in the journal Nature.
Originally published at Phys.org
